Pancreatic cancer risk after treatment of Hodgkin lymphoma

Graça M. Dores,Rochelle E. Curtis,F.E. van Leeuwen,Marilyn Stovall,Per Hall,Charles F. Lynch,Susan A. Smith,Rita E. Weathers,Hans H. Storm,David C. Hodgson,Ruth A. Kleinerman,Heikki Joensuu,Tom Børge Johannesen,Michael Andersson,Eric J. Holowaty,Magnus Kaijser,Eero Pukkala,Leila Vaalavirta,Sophie D. Fossa,Frøydis Langmark,Lois B. Travis,J. F. Fraumeni,Berthe M.P. Aleman,Lindsay M. Morton,Ethel S. Gilbert

Pancreatic cancer risk after treatment of Hodgkin lymphoma

2014

Background Although elevated risks of pancreatic cancer have been observed in long-term survivors of Hodgkin lymphoma (HL), no prior study has assessed the risk of second pancreatic cancer in relation to radiation dose and specific chemotherapeutic agents.

Keywords:

General surgery
Lymphoma
Pancreatic cancer
Radiation
Cancer
Medicine
Radiation therapy
Chemotherapy regimen
Chemotherapy
after treatment
Case-control study
Oncology
Internal medicine
hodgkin lymphoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations